Catherine Lindon
Doctor
Pharmacology
University of Cambridge
United States of America
Biography
Cath discovered her interest in cell biology at the Institut Pasteur in Paris, during postdoctoral studies of myogenic cell fate control. She returned to the UK with a Wellcome Trust Advanced Training Fellowship, to acquire expertise in live cell imaging of human cells with the Pines group at the Gurdon Institute in Cambridge. She subsequently set up her own research programme to study ubiquitin-mediated events in mitotic exit, with the support of a Career Development Award from the MRC. In 2008 she became a research group leader in the Department of Genetics and in 2015 will take up a lectureship in the Department of Pharmacology.
Research Interest
cell biology
Publications
-
Min M, Mayor U, Lindon C (2013).
Ubiquitination site preferences in anaphase promoting complex/cyclosome (APC/C) substrates. Open Biology 3 130097
-
Min M, Mayor U, Dittmar G, Lindon C (2014).
Using in vivo-biotinylated ubiquitin to describe a mitotic exit ubiquitome from human cells. Molecular & Cellular Proteomics 13 2411-2425
-
Lipinszki Z, Wang P, Grant R, Lindon C, Dzhindzhev NS, D'Avino PP, Przewloka MR, Glover DM and Archambault V (2014). Affinity Purification of Protein Complexes from Drosophila Embryos in Cell Cycle Studies. Methods in Molecular Biology 1170 571-588
